$415 Million is the total value of MPM BioImpact LLC's 12 reported holdings in Q3 2020. The portfolio turnover from Q2 2020 to Q3 2020 was 9.1% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| RPTX | Repare Therapeutics, Inc. | $73,489,000 | -0.8% | 2,388,337 | 0.0% | 17.71% | -10.1% | |
| TCRR | TCR2 Therapeutics, Inc. | $68,498,000 | +32.3% | 3,370,982 | 0.0% | 16.50% | +19.9% | |
| HARP | Harpoon Therapeutics, Inc. | $66,234,000 | +2.3% | 3,898,422 | 0.0% | 15.96% | -7.3% | |
| ITOS | New | iTeos Therapeutics, Inc. | $58,112,000 | – | 2,355,557 | +100.0% | 14.00% | – |
| EPZM | Buy | Epizyme, Inc. | $34,057,000 | -9.0% | 2,854,737 | +22.4% | 8.20% | -17.6% |
| MEI Pharma, Inc. | $31,630,000 | -24.5% | 10,137,859 | 0.0% | 7.62% | -31.5% | ||
| TPTX | Turning Point Therapeutics, Inc. | $26,967,000 | +35.3% | 308,686 | 0.0% | 6.50% | +22.6% | |
| ADCT | ADC Therapeutics, Inc. | $17,803,000 | -29.5% | 539,648 | 0.0% | 4.29% | -36.1% | |
| GTHX | G1 Therapeutics, Inc. | $16,445,000 | -52.4% | 1,423,794 | 0.0% | 3.96% | -56.9% | |
| YMAB | YmAbs Therapeutics, Inc. | $12,949,000 | -11.1% | 337,291 | 0.0% | 3.12% | -19.5% | |
| MRUS | Merus N.V. | $8,411,000 | -25.4% | 700,879 | 0.0% | 2.03% | -32.4% | |
| AUTL | Autolus Therapeutics Limited | $463,000 | -27.3% | 39,740 | 0.0% | 0.11% | -33.7% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR/A filed 2020-11-19
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| Harpoon Therapeutics, Inc. | 15 | Q2 2023 | 27.6% |
| Repare Therapeutics, Inc. | 14 | Q3 2023 | 19.7% |
| TCR2 Therapeutics, Inc. | 14 | Q1 2023 | 18.0% |
| iTeos Therapeutics, Inc. | 13 | Q3 2023 | 15.7% |
| G1 Therapeutics, Inc. | 13 | Q4 2022 | 13.3% |
| Y Mabs Therapeutics, Inc. | 12 | Q3 2022 | 5.4% |
| Cullinan Oncology, Inc. | 11 | Q3 2023 | 41.4% |
| Epizyme, Inc. | 11 | Q2 2022 | 22.1% |
| Oncorus, Inc. | 11 | Q2 2023 | 13.3% |
| Intellia Therapeutics, Inc. | 10 | Q3 2023 | 5.5% |
View MPM BioImpact LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-13 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| SC 13D/A | 2023-08-01 |
| SC 13D | 2023-06-12 |
| 4 | 2023-06-05 |
| 13F-HR | 2023-05-12 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-11 |
View MPM BioImpact LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.